Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists
ContributorsBrulhart, Laure Sophie; Nissen, Michaël; Chevallier, Paola; Gabay, Cem
Published inJoint bone spine, vol. 77, no. 6, p. 625-626
Publication date2010
Keywords
- Adult
- Antibodies, Monoclonal/therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents/therapeutic use
- Blood Sedimentation
- Crohn Disease/complications/drug therapy/genetics
- Drug Tolerance
- HLA-B27 Antigen/classification/genetics
- Humans
- Joints/pathology/physiopathology
- Male
- Psoriasis/complications/drug therapy/genetics
- Range of Motion, Articular
- Severity of Illness Index
- Spondylitis, Ankylosing/complications/drug therapy/genetics
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
- Uveitis/complications/drug therapy/genetics
Affiliation entities
Research groups
Citation (ISO format)
BRULHART, Laure Sophie et al. Tocilizumab in a patient with ankylosing spondylitis and Crohn’s disease refractory to TNF antagonists. In: Joint bone spine, 2010, vol. 77, n° 6, p. 625–626. doi: 10.1016/j.jbspin.2010.08.004
Main files (1)
Article (Published version)
Identifiers
- PID : unige:20807
- DOI : 10.1016/j.jbspin.2010.08.004
- PMID : 20851032
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1297319X10002150
Journal ISSN1297-319X
